Advanced search
Publication Cover
Leukemia & Lymphoma Volume 59, 2018 - Issue 9
Submit an article Journal homepage
660
Views
2
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Safety profile of lenalidomide in patients with lower-risk myelodysplastic syndromes without del(5q): results of a phase 3 trial

Antonio AlmeidaDepartamento de Hematologia, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal; Correspondence[email protected]
View further author information
,
Pierre FenauxService d’Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France; View further author information
,
Guillermo Garcia-ManeroMD Anderson Cancer Center, Houston, TX, USA; View further author information
,
Stuart L. GoldbergJohn Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA; View further author information
,
Stefanie GröpperMarien Hospital Düsseldorf, Düsseldorf, Germany; View further author information
,
Anna JonasovaFirst Faculty of Medicine, Charles University General Hospital, Prague, Czech Republic; View further author information
,
Norbert VeyInstitut Paoli-Calmettes, Centre Régional de Lutte Contre le Cancer, Marseilles, France; View further author information
,
Carmen CastanedaCelgene Corporation, Summit, NJ, USA; View further author information
,
Jianhua ZhongCelgene Corporation, Summit, NJ, USA; View further author information
,
C. L. BeachCelgene Corporation, Summit, NJ, USA; View further author information
&
Valeria SantiniAzienda Ospedaliero Universitaria Careggi, University of Florence, Florence, ItalyView further author information
 show all
Pages 2135-2143 | Received 16 Oct 2017, Accepted 20 Dec 2017, Published online: 11 Jan 2018

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.